Format

Send to

Choose Destination
Ann Nutr Metab. 2018 Nov 28;74(1):11-17. doi: 10.1159/000495037. [Epub ahead of print]

L-Carnitine Supplementation Increases Trimethylamine-N-Oxide but not Markers of Atherosclerosis in Healthy Aged Women.

Author information

1
Department of Bioenergetics and Nutrition, Gdansk University of Physical Education and Sport, Gdansk, Poland.
2
Latvian Institute of Organic Synthesis, Riga, Latvia.
3
Department of Health Sciences, Powislanski College, Kwidzyn, Poland.
4
Department of Bioenergetics and Nutrition, Gdansk University of Physical Education and Sport, Gdansk, Polandrobol@awf.gda.pl.

Abstract

BACKGROUND:

L-carnitine can be metabolized to trimethylamine N-oxide (TMAO), a molecule that promotes atherogenesis through its interaction with macrophages and lipid metabolism.

OBJECTIVE:

The aim of the present study was to assess whether L-carnitine supplementation may promote changes in selected serum biomarkers of atherosclerosis.

METHODS:

Before the start, in the mid-point and after completing the 24-weeks supplementation protocol, fasting blood samples were taken from the antecubital vein. Plasma free L-carnitine and TMAO were determined by the UPLC/MS/MS method. Serum proteins were determined by the enzyme immunoassay method using commercially available kits. Total cholesterol, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, and triglycerides have been determined using standard automatic analyzer.

RESULTS:

L-carnitine supplementation elevated fasting plasma carnitine in the mid-point of our study and it remained increased until the end of supplementation period. Moreover, it induced tenfold increase in plasma TMAO concentration but did not affect serum C-reactive protein, interleukin-6, tumour necrosis factor-α, L-selectin, P-selectin, vascular cell adhesion molecule-1, intercellular adhesion molecule-1 or lipid profile markers.

CONCLUSION:

We demonstrated that -although oral L-carnitine supplementation significantly -increased plasma TMAO concentration, no lipid profile changes or other markers of adverse cardiovascular events were detected in healthy aged women over the period of 24 weeks.

KEYWORDS:

Aging; Cardiovascular health; Inflammation

PMID:
30485835
DOI:
10.1159/000495037

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center